Total Synthesis of the Lipid Mediator PD1n-3 DPA: Configurational Assignments and Anti-inflammatory and Pro-resolving Actions
暂无分享,去创建一个
C. Serhan | M. Aursnes | T. Hansen | R. Colas | J. Dalli | A. Vik | J. E. Tungen | C. C. Cheng
[1] M. Aursnes,et al. Stereoselective synthesis of protectin D1: a potent anti-inflammatory and proresolving lipid mediator. , 2014, Organic & biomolecular chemistry.
[2] C. Serhan,et al. Neuroprotectin/protectin D1 protects against neuropathic pain in mice after nerve trauma , 2013, Annals of neurology.
[3] C. Serhan,et al. Resolution phase lipid mediators of inflammation: agonists of resolution. , 2013, Current opinion in pharmacology.
[4] C. Serhan,et al. Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents. , 2013, Chemistry & biology.
[5] Ira Tabas,et al. Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities , 2013, Science.
[6] A. Nagar,et al. A quantum theory for the irreplaceable role of docosahexaenoic acid in neural cell signalling throughout evolution. , 2013, Prostaglandins, leukotrienes, and essential fatty acids.
[7] T. Hansen,et al. Concise syntheses of three ω-3 polyunsaturated fatty acids , 2012 .
[8] C. Serhan,et al. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. , 2012, Blood.
[9] C. Serhan,et al. Resolvins and protectins in inflammation resolution. , 2011, Chemical reviews.
[10] M. Fornage,et al. Genetic Loci Associated with Plasma Phospholipid n-3 Fatty Acids: A Meta-Analysis of Genome-Wide Association Studies from the CHARGE Consortium , 2011, PLoS genetics.
[11] M. Garg,et al. Docosapentaenoic acid (22:5n-3): a review of its biological effects. , 2011, Progress in lipid research.
[12] D. Gilroy. ACUTE AND CHRONIC INFLAMMATION , 2010 .
[13] K. Hamazaki,et al. Artificial Rearing of Infant Mice Leads to n-3 Fatty Acid Deficiency in Cardiac, Neural and Peripheral Tissues , 2009, Lipids.
[14] C. Serhan,et al. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions , 2009, The Journal of experimental medicine.
[15] C. Serhan,et al. Endogenous pro‐resolving and anti‐inflammatory lipid mediators: a new pharmacologic genus , 2008, British journal of pharmacology.
[16] C. Serhan. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. , 2007, Annual review of immunology.
[17] A. Ochoa-Terán,et al. Model studies on the ring construction of the auriside macrolactone , 2006 .
[18] Yan Lu,et al. Anti-Inflammatory Actions of Neuroprotectin D1/Protectin D1 and Its Natural Stereoisomers: Assignments of Dihydroxy-Containing Docosatrienes1 , 2006, The Journal of Immunology.
[19] C. Serhan,et al. The Docosatriene Protectin D1 Is Produced by TH2 Skewing and Promotes Human T Cell Apoptosis via Lipid Raft Clustering* , 2005, Journal of Biological Chemistry.
[20] John Savill,et al. Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.
[21] P. Mukherjee,et al. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[22] C. Serhan,et al. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. , 2004, Prostaglandins & other lipid mediators.
[23] C. Serhan,et al. Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells , 2003, The Journal of Biological Chemistry.
[24] C. Serhan,et al. Resolvins , 2002, The Journal of experimental medicine.
[25] C. Clish,et al. Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing , 2000, The Journal of experimental medicine.
[26] F. Lee. Cells Tissues and Disease , 1997 .
[27] G. Majno,et al. Cells, tissues, and disease : principles of general pathology , 1996 .
[28] C. Serhan. Lipoxin biosynthesis and its impact in inflammatory and vascular events. , 1994, Biochimica et biophysica acta.
[29] K. Nicolaou,et al. Stereokontrollierte Totalsynthesen der Lipoxine A5 und B5 , 1987 .
[30] K. Nicolaou,et al. A General Strategy for the Synthesis of Monohydroxy-eicosatetraenoic Acids: Total Synthesis of 5(S)-Hydroxy-6(E),8,11,14(Z)-eicosatetraenoic Acid (5-HETE) and 12(S)-Hydroxy-5,8,14(Z), 10(E)-eicosatetraenoic Acid (12-HETE) , 1986 .
[31] E. Corey,et al. A stereoselective and practical synthesis of 5,6(S,S)-epoxy-15(S)-hydroxy-7(E),9(E),11(Z),13(E)-eicosatetraenoic acid (4), possible precursor of the lipoxins , 1986 .
[32] Y. Tohda,et al. A convenient synthesis of acetylenes: catalytic substitutions of acetylenic hydrogen with bromoalkenes, iodoarenes and bromopyridines , 1975 .
[33] E. Corey,et al. Protection of hydroxyl groups as tert-butyldimethylsilyl derivatives , 1972 .